chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Side of left thigh pain from hip to knee; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 15:00 (at the age of 56-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 15:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had seasonal allergies. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR), montelukast (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received codeine (MANUFACTURER UNKNOWN) taken for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date in Mar2021, next day after first dose, the patient experienced side of left thigh pain from hip to knee. On 16Apr2021 at 18:00, the patient experienced same pain, only the pain began 3 days after the second shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left thigh pain from hip to knee was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: headache; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8729) via an unspecified route of administration in the arm left on 07Apr2021 at 14:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 07Apr2021 at 20:00, the patient experienced headache and sore arm. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events headache and sore arm were resolved on an unknown date in Apr2021.    No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Headache, Migraine, Myalgia
Clinical narrative: Burning sensation in mouth from day one until today. 4/19/21. Not getting any better; Headaches; Migraine; Muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 06Apr2021 at 13:15 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine and food allergy to garlic. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received codeine (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rizatriptan benzoate (MAXALT), diclofenac sodium (CATAFLAM), docusate sodium (STOOL SOFTENER), curcuma longa (TURMERIC) and VITAMINS; all of them started from an unknown date for unspecified indication and unknown if ongoing.  On 06Apr2021, the patient experienced burning sensation in mouth which was not getting any better, headaches/migraines for 6 days and muscle pain for 5 days. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event- burning sensation in mouth was not recovered at the time of this report. The clinical outcome of the events- headaches/migraines was recovered on 12Apr2021. The clinical outcome of the event- muscle pain was recovered on 11Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Fatigue, Pain in extremity, Rash
Clinical narrative: 48 hr post injection: affected arm (L) became very hot; Rash developed upper L arm; developed upper L arm pain; Spiked a temperature of 102F; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0151) via an unspecified route of administration in the left arm on 07Apr2021 at 16:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included verapamil (MANUFACTURER UNKNOWN), hydrochlorothiazide, losartan (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously took flu vaccine (INFLUENZA VACCINE) for unknown indication on unknown date and experienced allergy. Also the patient previously took tizanidine hydrochloride(TIZANIDINE) for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6206) via an unspecified route of administration in the left arm on unknown date in Mar2021 at 16:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. On 08Apr2021, 24 hours post injection, the patient experienced spike in temperature for 102 degree Farenheit (degF) and fatigue. On 09Apr2021, 48 hours post injection, the patient upper left arm developed very hot, rash and pain. On 08Apr2021, the patient underwent lab test which included body temperature and the result was 102 (degF).Therapeutic measure was taken for the event spike in temperature which included MOTRIN. No therapeutic measures were taken as a result of the other reported events fatigue, upper left arm hot, rash and pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events spike in temperature for 102F was recovered after 4 hours on 08Apr2021, while that of the events upper left arm hot, rash and pain lasted for 3 days on 12Apr2021 and the outcome of the event fatigue was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: 48 hr post injection: affected arm (L) became very hot; Rash developed upper L arm; developed upper L arm pain; Spiked a temperature of 102F; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0151) via an unspecified route of administration in the left arm on 07Apr2021 at 16:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included verapamil (MANUFACTURER UNKNOWN), hydrochlorothiazide, losartan (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. The patient previously took flu vaccine (INFLUENZA VACCINE) for unknown indication on unknown date and experienced allergy. Also the patient previously took tizanidine hydrochloride(TIZANIDINE) for unknown indication on unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6206) via an unspecified route of administration in the left arm on unknown date in Mar2021 at 16:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. On 08Apr2021, 24 hours post injection, the patient experienced spike in temperature for 102 degree Farenheit (degF) and fatigue. On 09Apr2021, 48 hours post injection, the patient upper left arm developed very hot, rash and pain. On 08Apr2021, the patient underwent lab test which included body temperature and the result was 102 (degF).Therapeutic measure was taken for the event spike in temperature which included MOTRIN. No therapeutic measures were taken as a result of the other reported events fatigue, upper left arm hot, rash and pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events spike in temperature for 102F was recovered after 4 hours on 08Apr2021, while that of the events upper left arm hot, rash and pain lasted for 3 days on 12Apr2021 and the outcome of the event fatigue was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Headache
Clinical narrative: Lower left back pain; headache; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old unknown gender patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 07Apr2021 at 10:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included lisinopril (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. On 08Apr2021, the patient experienced lower left back pain, headache and fatigue. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lower left back pain, headache and fatigue were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: Sore arm; Chills; Headache; Body ache; Fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 18Apr2021 at 14:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included congenital heart disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included acetylsalicylic acid (ASPIRIN) and beta blocker; both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 28Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced sore arm, chills, headache, body ache, fatigue and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, chills, headache, body ache, fatigue and nausea was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; Chills; Headache; Body ache; Fatigue; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 18Apr2021 at 14:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included congenital heart disease. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included acetylsalicylic acid (ASPIRIN) and beta blocker; both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 28Mar2021 at 13:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021, the patient experienced sore arm, chills, headache, body ache, fatigue and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, chills, headache, body ache, fatigue and nausea was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Mass
Clinical narrative: Lump on her collar bone; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 18Apr2021 at 00:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 19Apr2021, the patient discovered a lump on the collar bone in the arm where she received the vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of adverse event. The clinical outcome of the event lump on her collar bone was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nasal congestion, Pain
Clinical narrative: Nasal congestion; Significant body aches; Tiredness; Chills; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 09:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ethinylestradiol/ ferrous fumarate/ norethisterone acetate (LO LOESTRIN FE) and multivitamin (MANUFACTURER UNKNOWN) from unknown dates for unknown indications and unknown if ongoing. The patient previously received metoclopramide (REGLAN) and amoxicillin/clavulanic acid (AUGMENTIN) on unknown dates for unknown indications and experienced drug allergy. On 17Apr2021 at 20:00, (also reported as about 24-36 hours after the vaccine), the patient experienced tiredness, significant body aches, chills, and nasal congestion for several days. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tiredness, significant body aches, chills, and nasal congestion were recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: U
Vaccine: COVID19
Symptoms: Dehydration, Somnolence
Clinical narrative: Dehydration; Drowsiness; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 14:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 11Apr2021 at 15:00, the patient experienced dehydration and drowsiness. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were not taken as a result of reported events. The clinical outcomes of events dehydration and drowsiness were unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Tenderness
Clinical narrative: tenderness; swollen lymph nodes; headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21Apr2021 at 08:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medication within two weeks of the COVID-19 vaccine. On an unknown date in 2021, the patient experienced fatigue, headache, tenderness, swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, headache, tenderness, swollen lymph nodes was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Enlarged lymph nodes around left upper quadrant of the armpit and left subclavicle; Enlarged lymph nodes around left upper quadrant of the armpit and left subclavicle; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EAW0161) via an unspecified route of administration in the left arm on 19Apr2021 at 10:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant past medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included prenatal vitamin; taken for unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 29Mar2021 at 10:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 10:00, the patient experienced enlarged lymph nodes around left upper quadrant of the armpit and left sub clavicle. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event enlarged lymph nodes around left upper quadrant of the armpit and left subclavicle was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: Lump on left side of neck.  Diagnosed in hospital as swollen lymph node side effect from shot; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 04Apr2021 at 10:30 (at the age of 19-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:00, the patient experienced lump on left side of neck. It was diagnosed in the hospital as swollen lymph node as a side effect from the shot. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event swollen lymph node and included treatment with pain medicines (Unspecified). Since the vaccination, the patient had been tested for COVID-19. On 12Apr2021, the patient underwent COVID-19 Nasal swab test and the result was negative. The clinical outcome of the event swollen lymph node was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Left leg swells after receiving shot in left arm; right leg is also swelling since receiving shot in right arm; This is a spontaneous report from a contactable consumer, the patient. An 83-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Feb2021 at 16:15 (at the age of 83-years-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 25Feb2021 (at the age of 83-years-old); both as a single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure, high cholesterol, dry eyes, arthritis, mild stroke and known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously took naproxen (MANUFACTURER UNKNOWN), fosinopril sodium (MONOPRIL), verapamil (reported as CALAN), benzocaine (MANUFACTURER UNKNOWN) and beni are (as reported); all for unspecified indication from unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04Feb2021, patient's left leg got swollen after receiving shot in left arm. On 25Feb2021, patient's right leg got swollen after receiving shot in right arm. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left leg swells after receiving shot in left arm was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Full body chills; Teeth-chattering shivering; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 22Apr2021 at 13:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included iron supplement (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 01Apr2021 at 13:30 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 23Apr2021 at 03:00, the patient experienced full body chills and teeth-chattering shivering 13-15 hours after injection. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events full body chills and teeth-chattering shivering were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, SARS-CoV-2 test
Clinical narrative: Abdomen began hurting the following morning around 7 AM. It felt different than hunger pain. It feels superficial. It hurts from the left lower ribs to the right lower ribs, and from the stomach down to belly button.; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 22Apr2021 at 13:30 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included melatonin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 25Mar2021 at 14:00 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 06:30, the patient experienced abdomen began hurting the following morning around 07:00, felt different than hunger pain, it felts superficial and hurts from left lower ribs to right lower ribs and from the stomach down to belly button. There was a consistent pain that has been lasting for the past 2 hours, even after eating food. Food didn't provide relief. She had been drinking multiple 12 oz. cups of water throughout the day the past three days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. On 21Apr2021, the patient underwent saliva test and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event abdomen pain was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: shaking as if chilled or nervous; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 11Apr2021 at 11:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included glatiramer acetate (MANUFACTURER UNKNOWN), mirtazapine (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (FLUOX); all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Apr2021, the patient experienced shaking as if chilled or nervous. Therapeutic measures were not taken as a result of the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shaking as if chilled or nervous was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: The glands near right collar bone are swollen and tender; The glands near right collar bone are swollen and tender; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 20Apr2021 at 08:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to egg whites, peanuts and dairy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 30Mar2021 at 07:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient previously also received gentamicin sulfate (GENTAK) on an unknown date and experienced drug allergy. On 21Apr2021 at 13:00, the patient reported that the glands near right collar bone were swollen and tender. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events glands near right collar bone were swollen and tender was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymph node pain, Lymphadenopathy, Peripheral swelling
Clinical narrative: Very swollen and painful lymph node at right clavicle; Very swollen and painful lymph node at right clavicle; Smaller swelling in lymph node in the right arm pit; Smaller swelling in lymph node in the right arm pit, some arm; Tired; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8731) via an unspecified route of administration in the right arm on 19Apr2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Concomitant medication included ibuprofen (MOTRIN); taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the second dose of varicella zoster vaccine (MANUFACTURER UNKNOWN) in the right arm on 04Mar2021. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 29Mar2021 at 14:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 19Apr2021 at 20:00, the patient experienced very swollen and painful lymph node at right clavicle and smaller swelling in lymph node in the right arm pit, some arm, and felt tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very swollen and painful lymph node at right clavicle, smaller swelling in lymph node in the right arm pit, some arm and the event tired were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Malaise, Vomiting
Clinical narrative: Flu like symptoms.; Feel sick; Throwing up; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Apr2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On 22Apr2021, approximately 6-8 hours later, the patient started to feel sick, throwing up and flu like symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events patient started to feel sick, throwing up and flu like symptoms were resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle swelling
Clinical narrative: The muscles above knee have swollen larger than  knees; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 04Apr2021 at 11:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included RA (rheumatoid arthritis) and fibromyalgia. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included folic acid (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3) and hydroxychloroquine (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 07Apr2021, the patient experienced muscles above knee had swollen larger than knees. She was taken off methotrexate two weeks prior to the first vaccination and was going to resume two weeks after most recent vaccination. This had not happened in previous flare-ups. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported event. The clinical outcome of event the muscles above knee had swollen larger than knees was not recovered at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 22Apr2021 at 13:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: have had pins and needles since shortly after the vaccine. It started out muted on right thigh, then on the bottom of left foot - and then strengthen in intensity - through out my body; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN7203) via an unspecified route of administration in the right arm on 05Apr2021 at 11:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included back pain [Occasional back pain (not for years though)]. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included vitamins nos, minerals nos, nutrients nos (MINERALS NOS; NUTRIENTS NOS; VITAMINS NOS) from unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 11:15, the patient experienced pins and needles since shortly after the vaccine. It started out muted on right thigh, then on the bottom of left foot - and then strengthen in intensity - throughout the body. Left finger, right calf, too left of her head, right eye lid, across stomach - sporadic and random - lasting anywhere from a flash to five seconds, up to 10 seconds - typically a flash. The muted pins and needles lasted 3 days, then strengthened, and were consistent in strength - and continued to be random and sporadic with no pattern. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pins and needles flash was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity
Clinical narrative: Right leg was number/in pain from the groin to the foot.; Right leg was number/in pain from the groin to the foot.; The top of both feet started to hurt. 23 days after the first shot and the top of both feet still hurt.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration on 01Apr2021 at 09:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic pelvic pain syndrome (CPPS). The patient had known allergies to sulfamethoxazole; trimethoprim (BACTRIM) and ciprofloxacin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ascorbic acid (VITAMIN C), bromelains (MANUFACTURER UNKNOWN), biotin (MANUFACTURER UNKNOWN) and quercetin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 01:30, 16 hours after the vaccination, the patient experienced right leg was number/in pain from the groin to the foot and at that same time patient experienced top of both feet started to hurt. On 23Apr2021, 23 days after the first shot, the patient still experienced top of both feet hurt and right leg still had mild discomfort. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right leg was number/in pain from the groin to the foot and top of both feet started to hurt was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Really sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EWO151) via an unspecified route of administration in the right arm on 02Apr2021 at 12:30 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included mometasone furoate (ASMANEX) and montelukast (MANUFACTURER UNKNOWN), all from unknown dates and for unknown indications. On 02Apr2021 at 13:30, the patient experienced really sore arm. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient received treatment for the reported event which included ibuprofen. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event really sore arm was recovered on an unknown date in Apr2021.    No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: vision is blurry. When look at the computer screen it looks blurry and am leaning forward to try to see the screen more clearly.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 16Apr2021 at 16:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID), amlodipine besilate (NORVASC), ascorbic acid, pyridoxine hydrochloride, biotin, folic acid, thiamine, nicotinic acid, pantothenic acid, riboflavin, betacarotene, iron, magnesium, manganese, molybdenum, potassium, chromium, copper, vanadium, zinc, calcium, iodine, phosphorus, selenium, vitamin d nos, vitamin k nos, vitamin b12 nos, chloride, xantofyl, nickel, silicon, vitamin e nos (CENTRUM SILVER WOMEN) and colecalciferol (VITAMIN D3); all from an unknown date for unspecified indication and unknown if ongoing. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) on unknown date for an unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 08:30, the patient experienced vision was blurry. When she looked at the computer screen, it looked blurry, and she was leaning forward to saw the screen more clearly. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event blurry vision was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.